Humacyte (HUMA) executive compensation, 2026 proxy

Laura E. Niklason, President and Chief Executive Officer, was paid $5.2M in 2025, up 478% from $905,436 the year before.

Filed
April 28, 2026
Annual meeting
June 9, 2026
Pay year
2025
Named executives
3
CEO total pay
$5.2M+478% vs prior year
CEO 2025 Total Pay
$5,234,908Significant increase over prior year
Corporate Bonus Payout
80%Based on corporate objectives achievement
CEO Salary
$633,606Base salary for 2025
CFO Total Pay
$2,131,658Total compensation for Dale A. Sander

How Niklason was paid

$5.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary12%Bonus5%Option awards83%All other compensation0%

Named executive officers

ExecutiveTotal
Laura E. NiklasonPresident and Chief Executive Officer$5,234,908
Dale A. SanderChief Financial Officer, Chief Corporate Development Officer and Treasurer$2,131,658
Shamik J. ParikhChief Medical Officer$2,096,556

What changed and why

  • $5.2MCEO total compensation was $5,234,908 in 2025 compared to $905,436 in 2024.
  • $4.3MOption awards for the CEO totaled $4,332,725 in 2025 due to annual and special option grants.
  • 80%Annual cash bonuses for executive officers were based on an 80% achievement payout of corporate objectives.
  • $634KDr. Laura E. Niklason received a base salary of $633,606 for fiscal 2025.
  • $2.1MDale A. Sander received total compensation of $2,131,658 in fiscal 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.